awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35022505-DC9E634A-34F7-4CAF-AE78-DCB6052E42AE
Q35022505-DC9E634A-34F7-4CAF-AE78-DCB6052E42AE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35022505-DC9E634A-34F7-4CAF-AE78-DCB6052E42AE
Inhibition of the Bcr-Abl tyrosine kinase as a therapeutic strategy for CML.
P2860
Q35022505-DC9E634A-34F7-4CAF-AE78-DCB6052E42AE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35022505-DC9E634A-34F7-4CAF-AE78-DCB6052E42AE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cdacde45b48e5dc44d6c915c88db30e521611e5d
P2860
A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias.